Laevoroc
http://www.laevoroc.comSpearheading the development of a novel PNP inhibitor poised to revolutionize treatment for leukaemia patients facing relapse post-stem cell transplantation. ... Read More
Laevoroc Company Contacts
Contacts
Country
Switzerland
City
Hünenberg
Headquarters
Hünenberg , Zug
Profile
Founded
2019
Industry
Biotechnology Research
Size
2 - 10
Specialties
Oncology
Funding
Total Rounds
1
Last Round
Mon May 10 2021
Last Round Series
Seed
Last Round Raised
$ 1,100,000